An interventional study of high-intensity laser acupuncture and Exercise therapy program and Sham laser acupuncture in Chronic Nonspecific Low-back Pain, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2024-09-23.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The purpose of this study is to investigate the efficacy of high-intensity laser acupuncture on peak torque, power of trunk extensors and flexors, back pain, range of motion, function, and satisfaction in patients with chronic nonspecific low back pain (CNLBP).
Chronic nonspecific low back pain (CNLBP) is a persistent back pain that affects people of all ages and contributes to the global disease burden. Treatment focuses on reducing pain and its consequences. High-intensity laser therapy is a non-invasive, painless modality that can be easily administered for various conditions. It has been proven to significantly reduce pain, with anti-inflammatory, anti-edematous, and analgesic effects. Laser photobiomodulation (PBM) therapy is a non-invasive and painless method that stimulates cells, pain receptors, and the immune system and can cause vasodilation and analgesic effects. Acupuncture is a common complementary therapy that has been proven to treat musculoskeletal pain and enhance muscle strength, and high-intensity laser acupuncture (HILA) has been promoted as an alternative to traditional needle acupuncture. HILA, as a non-invasive treatment, combines the efficacy of high-intensity laser and acupuncture in musculoskeletal pain management. Due to a lack of research, this study will examine the effects of HILA on peak torque and power of the trunk extensors and flexors, back pain, range of motion, function, and satisfaction in patients with chronic non-specific low back pain.
2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.
This study's enrollment of 60 is close to the median of 60 across 1,941 interventional studies indexed under Back Pain.
Browse Back Pain studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The patients will receive high-intensity laser acupuncture and an exercise therapy program.three times a week for four weeks.
Device: high-intensity laser acupuncture and Exercise therapy program
The patients will receive a sham acupuncture laser and an exercise therapy program three times a week for four weeks.
Other: Sham laser acupuncture
The experimental group will receive high-intensity lasers and the treatment will be performed at 15 acupuncture points: unilateral GV3, GV4, and GV5, and bilateral BL 20, BL23, BL24, BL25, BL40 and GB30. Exercise therapy program The patients will perform an exercise therapy program in the form of: * strengthening exercises for abdominal and back muscles, * lumbar stabilization exercises. * stretching exercises.
Also known as: high-power laser acupuncture
Sham laser acupuncture and exercise therapy program The patients will receive a sham laser.acupuncture and an exercise therapy program in the form of: * strengthening exercises for abdominal and back muscles, * lumbar stabilization exercises. * stretching exercises.
peak torque
Isokinetic dynamometer will be used for measuring peak torque of back extensors and flexors.
Time frame: up to four weeks
peak torque
Isokinetic dynamometer will be used for measuring peak torque of back extensors and flexors..
Time frame: follow up after 1 month
Average Power
Isokinetic dynamometer will be used for measuring Average Power in watts for both back extensors and flexors.
Time frame: up to four weeks
Average Power
Isokinetic dynamometer will be used for measuring Average Power in watts for both back extensors and flexors.
Time frame: follow up after 1 month
Pain Intensity
Visual Analogue Scale (VAS) will be used by the patient to mark his/her level of pain between 0 to100 milliliters line. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Time frame: up to four weeks
Pain Intensity
Visual Analogue Scale (VAS) will be used by the patient to mark his/her level of pain between 0 to100 milliliters line. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Time frame: follow up after 1 month
lumbar flexion and extension ROM assessment
Modified-modified Schober test will be used to assess ROM of lumbar flexion and extension
Time frame: up to four weeks
lumbar flexion and extension ROM assessment
Modified-modified Schober test will be used to assess ROM of lumbar flexion and extension
Time frame: follow up after 1 month
Disability
Arabic version of Oswestry Disability Index (ODI) will be used for assessment of functional disability.
Time frame: up to four weeks
Disability
Arabic version of Oswestry Disability Index (ODI) will be used for assessment of functional disability.
Time frame: follow up after 1 month
patient Satisfaction
The satisfaction VAS will be used to measure patient satisfaction. The patient will be by placing an indicator at 0 to100 milliliters line. Zero usually represents 'no satisfaction at all' whereas the upper limit represents 'the best satisfaction ever'.
Time frame: up to four weeks
patient Satisfaction
The satisfaction VAS will be used to measure patient satisfaction. The patient will be by placing an indicator at 0 to100 milliliters line. Zero usually represents 'no satisfaction at all' whereas the upper limit represents 'the best satisfaction ever'.
Time frame: follow up after 1 month
This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University